Committed to sharing our science

Committed to sharing our science

339 results available

Global Remodeling Changes with Aficamten in Patients with Obstructive Hypertrophic Cardiomyopathy: An Analysis of the SEQUOIA-HCM Trial

Oral Presentation, HCM Society 2024

Owens, AT et al

September 27, 2024
Clinical Evaluation of the Effect of Aficamten on QT/QTc Interval in Healthy Participants

Poster, American College of Clinical Pharmacology 2024

Maharao N, et al

September 8, 2024
A First-in-Human, Single and Multiple Ascending Dose Study of CK-4021586, a Novel Cardiac Myosin Inhibitor

Poster, American College of Clinical Pharmacology 2024

Lutz JD, et al

September 8, 2024
Aficamten and Cardiopulmonary Exercise Test Performance: A Substudy of the SEQUOIA-HCM Randomized Clinical Trial

Journal of the American Medical Association – Cardiology

Lee, M et al

September 4, 2024
Impact of Aficamten on Echocardiographic Cardiac Structure and Function in Symptomatic Obstructive Hypertrophic Cardiomyopathy

Journal of the American College of Cardiology

Hegde, S et al

September 1, 2024